Neurotoxins and Sweating Lexington KY

Neurotoxins For Treating Hyperhidrosis (Excessive Sweating)

Botox is FDA-approved for the treatment of excessive sweating when medications and antiperspirants are proven ineffective. Other neurotoxins such as Dysport and Xeomin work the same way as Botox in reducing excess sweating. Once injected, the neurotoxin temporarily blocks the secretion of the chemical that is responsible for “turning on” the body’s sweat glands. In other words, the neurotoxin blocks the communication between nerves and sweat glands.

What Areas of the Body can Be Treated with Neurotoxins?

Neurotoxins are safe and effective for treating excessive sweating in body areas such as the:

  • Armpits
  • Hands
  • Feet
  • Head
  • Face
  • Other relatively small body areas (like under the breasts)

What to Expect During Your Appointment

The actual process requires relatively little time, with most medical professionals able to complete the injection(s) in under 20 minutes. The injections are very shallow. Thus, the medicine is injected just below the surface of the skin, where it remains. There are typically no side effects or physical restrictions after the procedure.

What to Expect After Your Treatment

Results are noticeable approximately 2 to 4 days after treatment, with the full effects within 2 weeks. The neurotoxin injections do not cure excessive sweating, it only controls it. The symptoms will return gradually. Every person breaks down neurotoxins differently, so the duration of the results will vary. Results typically last 4 to 12 months. Repeated, regular treatment results in long-lasting improvements in excessive sweating symptoms

Is This Right Treatment for my Excessive Sweating?

When it comes to controlling excess sweating, experience matters. Be Medispa can determine which neurotoxin is the best to treat your sweat issue. Call us today at (859) 266-5483 to discuss with us how we can help you with your excessive sweating. Or you can click here today to make an appointment.

© All Rights Reserved, Company BeMedispa 2024